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Cellular/Molecular
Calpains Are Downstream Effectors of bax-Dependent
Excitotoxic Apoptosis
Beatrice D’Orsi,1 Helena Bonner,1 Liam P. Tuffy,1 Heiko Du¨ssmann,1 InaWoods,1 Michael J. Courtney,2
ManusW.Ward,1 and Jochen H. M. Prehn1
1Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Royal College of Surgeons in Ireland, Dublin 2, Ireland, and
2Molecular Signalling Laboratory, Department of Neurobiology, A. I. Virtanen Institute, University of Eastern Finland, 70210 Kuopio, Finland
Excitotoxicity resulting fromexcessive Ca2 influx through glutamate receptors contributes to neuronal injury after stroke, trauma, and
seizures. Increased cytosolic Ca2 levels activate a family of calcium-dependent proteaseswith papain-like activity, the calpains.Herewe
investigated the role of calpain activation during NMDA-induced excitotoxic injury in embryonic (E16–E18) murine cortical neurons
that (1) underwent excitotoxic necrosis, characterized by immediate deregulation of Ca2 homeostasis, a persistent depolarization of
mitochondrialmembrane potential (m), and insensitivity to bax-gene deletion, (2) underwent excitotoxic apoptosis, characterized by
recovery of NMDA-induced cytosolic Ca 2 increases, sensitivity to bax gene deletion, and delayedm depolarization and Ca
2 dereg-
ulation, or (3) that were tolerant to excitotoxic injury. Interestingly, treatment with the calpain inhibitor calpeptin, overexpression of the
endogenous calpain inhibitor calpastatin, or gene silencing of calpain protected neurons against excitotoxic apoptosis but did not
influence excitotoxic necrosis. Calpeptin failed to exert a protective effect in bax-deficient neurons but protected bid-deficient neurons
similarly to wild-type cells. To identify when calpains became activated during excitotoxic apoptosis, we monitored calpain activation
dynamics by time-lapse fluorescence microscopy using a calpain-sensitive Fo¨rster resonance energy transfer probe. We observed a
delayed calpainactivation that occurreddownstreamofmitochondrial engagement anddirectlyprecededneuronal death. In contrast,we
could not detect significant calpain activity during excitotoxic necrosis or in neurons that were tolerant to excitotoxic injury. Oxygen/
glucose deprivation-induced injury in organotypic hippocampal slice cultures confirmed that calpainswere specifically activated during
bax-dependent apoptosis and in this setting function as downstream cell-death executioners.
Introduction
Overactivation of glutamate receptors (“excitotoxicity”) has been
implicated in the pathophysiology of stroke (Zipfel et al., 1999)
and several chronic neurodegenerative disorders (Rothstein et
al., 1990; Lipton, 2007; Mattson, 2007). The excessive activation
of NMDA and AMPA receptors significantly disrupt cellular ion
homeostasis. As a result, a primarily Ca2-dependent cell death
occurs (Choi, 1987). After an intense and sustained period of
glutamate receptor overactivation, the loss of ion homeostasis is
frequently irreversible, ATP levels deplete, and excitotoxic necro-
sis is activated (Tymianski et al., 1993; Ankarcrona et al., 1995;
Budd and Nicholls, 1996; White and Reynolds, 1996; Vergun et
al., 1999;Ward et al., 2000). Conversely, transient ionic overload-
ing often results in a less severe disturbance, allowing the cells to
initially recover and restore their ionic gradients. Nevertheless,
after the insult, neurons can either build on their initial recovery
and survive or initiate a cell-death machinery, resulting in exci-
totoxic apoptosis (Ankarcrona et al., 1995; Lankiewicz et al.,
2000; Luetjens et al., 2000). A number of studies addressed the
differential activation of apoptosis and necrosis, in particular
during ischemic brain injury (Manabat et al., 2003; Liu et al.,
2004; Wei et al., 2004). Previous studies have shown excitotoxic
apoptosis to induce the release of pro-apoptotic factors from
mitochondria, including cytochrome c and apoptosis-inducing
factor (AIF) (Budd et al., 2000; Lankiewicz et al., 2000; Luetjens et
al., 2000; Cregan et al., 2002;Wang et al., 2004;Ward et al., 2006).
The mitochondrial apoptosis pathway is controlled by pro- and
anti-apoptotic Bcl-2 family proteins and either overexpression of
anti-apoptotic bcl-2 or bcl-xL, or gene deficiency in the pro-
apoptotic bax or bim genes to prevent excitotoxic apoptosis
(Xiang et al., 1998;Wang et al., 2004; Dietz et al., 2007; Semenova
et al., 2007; Concannon et al., 2010). In most cells, the release of
cytochrome c activates a family of cysteine proteases, the
caspases, by binding to apoptotic protease-activating factor-1
(APAF-1) (Liu et al., 1996; Zou et al., 1997). In neurons, however,
caspase activation is frequently suboptimal despite the engage-
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ment of the mitochondrial apoptosis pathway (Budd et al., 2000;
Lankiewicz et al., 2000). This phenomenonmay be attributable to
high expression levels of the caspase inhibitor XIAP (X-linked
inhibitor of apoptosis protein) (Potts et al., 2003) or reduction in
protein levels of APAF-1 during neuronal maturation (Wright et
al., 2007).
Of note, the activation of the Ca2-activated neutral cysteine
protease calpain I has also been implicated in excitotoxic neuron
death (Siman et al., 1989; Brorson et al., 1995; Lankiewicz et al.,
2000). Similar to caspases, calpain I cleaves a variety of cytoskeletal
proteins, enzymes, and transcription factors andmay induce mor-
phological alterations that mimic caspase-dependent apoptosis
(Croall and Demartino, 1991; Wolf et al., 1999). Furthermore,
calpain has been shown to cleave and inactivate pro-caspase 9,
pro-caspase-3, and APAF-1 (Chua et al., 2000; Lankiewicz et al.,
2000; Reimertz et al., 2001). Because calpains are activated by
significant increases in cytosolic Ca2, calpains may specifically
play a role in cell demolition during excitotoxic necrosis, but this
has not yet been experimentally tested. Using a combined bio-
chemical, pharmacological, and single-cell imaging approach, we
demonstrate here that calpains are required for the execution of
bax-dependent excitotoxic apoptosis but surprisingly play no sig-
nificant role during excitotoxic necrosis.
Materials andMethods
Materials. Fetal calf serum, fetal bovine serum, horse serum, B27 supplement,
minimal essential medium (MEM), Neurobasal medium, tetramethylrhod-
amine methyl ester (TMRM), Fluo-4 AM, and 1,2-bis-(o-aminophenoxy)-
ethane-N,N,N,N-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM)
were from Invitrogen (Bio Sciences). Calpeptin was purchased from ENZO
Life Sciences and ionomycin from Merck Biosciences. All other chemicals,
including NMDA and MK-801, came in analytical grade purity from
Sigma-Aldrich.
Gene-targeted mice. The generation and genotyping of bid/ mice has
beendescribedpreviously (Kaufmannet al., 2007). Several pairs of heterozy-
gous breeder pairs of bax-deficient mice were obtained from The Jackson
Laboratory and maintained in house. The genotype of bax/ mice was
confirmed by PCR as described by The Jackson Laboratory (http://jaxmice.
jax.org/protocolsdb/f?p116:2:863695382966767::NO:2:P2_MASTER_
PROTOCOL_ID,P2_JRS_CODE:250,002994). The bid/ mice was
generated on an inbredC57BL/6 background, using C57BL/6-derived ES
cells. The bax/ mice were originally generated on a mixed C57BL/
6129SV genetic background, using 129SV-derived ES cells but had
been backcrossed for12 generations onto the C57BL/6 background.
DNA extraction and genotyping. DNA was extracted from tail snips
using High Pure PCR Template Preparation Kit (Roche). Genotyping
was performed using three specific primers as follows: 5GGTCTGT-
GTGGAGAGCAAAC3 (common), 5TCAGGTGCCAGTGGAGAT-
GAACTC3 [wild-type (WT) allele-specific], and 5GAGTCATA-
CTTACTTCCTCCGAC3 (mutant allele-specific) for bid; and 5GTT-
GACCAGAGTGGCGTAGG3 (common), 5GAGCTGATCAGAAC-
CATCATG3 (WT allele-specific), and 5CCGCTTCCATTGCTCA-
GCGG3 (mutant allele-specific) for bax. The sizes of the expected PCR
products are illustrated in Figure 4A.
Preparation of mouse neocortical neurons. Primary cultures of cortical
neurons were prepared from E16 to E18 as described previously (Con-
cannon et al., 2010). To isolate the cortical neurons, hysterectomies of the
uterus of pregnant female mice were performed using an abdominal
injection of 40 mg/kg pentobarbital (Dolethal) as lethal anesthesia. The
cerebral cortices were pooled in a dissection medium on ice (PBS with
0.25% glucose and 0.3% bovine serum albumin). The tissue was incu-
bated with 0.25% trypsin–EDTA at 37°C for 15 min. After the incuba-
tion, the trypsinization was stopped by the addition of medium
containing sera. The neurons were then dissociated by gentle pipetting,
and, after centrifugation (800  g for 3 min), the medium containing
trypsin was aspirated. Neocortical neurons were then resuspended in
fresh plating medium (MEM containing 5% fetal calf serum, 5% horse
serum, 100U/ml penicillin/streptomycin, 0.5mM L-glutamine, and 0.6%
D-glucose). Cells were plated at 2 105 cells/cm2 on poly-lysine-coated
plates and incubated at 37°C, 5% CO2. The plating medium was ex-
changed with 50% feeding medium (Neurobasal medium embryonic
containing 100 U/ml Pen/Strep, 2% B27, and 0.5 mM L-glutamine) and
50% plating medium with additional cytosine arabinofuranoside (600
nM). Two days later, the medium was again exchanged for complete
feedingmedium. All experiments were performed on days in vitro (DIV)
8–11. All animal work was performed with ethics approval and under
licenses granted by the Irish Department of Health and Children.
Cell lines. Human SH-SY5Y neuroblastoma cells were grown in
DMEM/Ham’s F-12 (1:1 mixture) culture medium (Lonza) supple-
mented with 15% fetal calf serum and 100 U/ml penicillin/streptomycin.
The motor neuron-like cell line NSC34 was maintained in DMEM
(Lonza) supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
and 100 U/ml penicillin/streptomycin.
Preparation of organotypic hippocampal slice cultures.Organotypic hip-
pocampal slices cultures (OHSCs) were prepared and cultured according
to themodified procedure (Kristensen et al., 2001). The brain from post-
natal day 10 mouse pups was isolated and transferred to dissection me-
diumcontainingHBSS (Invitrogen), 20mMHEPES, 100U/ml penicillin/
streptomycin, and 0.65% glucose. Isolated hippocampi were placed on a
McIlwain tissue chopper (Mickle Laboratory Engineering) and cut into
450-m-thick sections. The slices were then transferred into fresh dis-
section medium and selected for clear hippocampal morphology (intact
CA regions and dentate gyrus) and placed on porous (0.4 m) mem-
brane of Millicell inserts (Millipore). The inserts were placed in six-well
tissue culture plates with 1 ml of culture medium consisting of MEM
supplemented with 25% horse serum, 4 mM L-glutamine, 6 mg/ml
D-glucose, 2% B27, 50 U/ml penicillin G, and 50 g/ml streptomycin.
The slices were maintained in a humidified incubator with 5% CO2 at
35°C with media changes every second day. All experiments were per-
formed at DIV 10.
Determination of neuronal injury: Hoechst and propidium iodide stain-
ing of nuclear chromatin. Neocortical neurons on 24-well plates were
stained live with 1 g/ml Hoechst 33258 (Sigma) and 5 M propidium
iodide (PI) (Sigma) dissolved in culture medium. Hoechst 33342 stains
the condensed chromatin in apoptotic cells more brightly than the chro-
matin in healthy cells. The intact membrane of living cells excludes cat-
ionic dyes, such as PI. PI, a cell-impermeable red fluorescent dye,
intercalates with nucleic acids in cells with membrane leakage. Nuclear
morphology was assessed using an Eclipse TE 300 inverted microscope
(Nikon) with 20, 0.43 NA phase-contrast objective using the appropri-
ate filter set for Hoechst, PI, and a charge-coupled device camera (SPOT
RT SE 6; Diagnostic Instruments). All experiments were performed at
least three times with independent cultures, and, for each time point,
images of nuclei were captured in three subfields containing300–400
neurons each and repeated in triplicate. The number of PI-positive cells
was expressed as a percentage of total cells in the field. Resultant images
were processed using NIH Image J (Wayne Rasband, National Institutes
of Health, Bethesda, MD).
Oxygen–glucose deprivation in OHSCs. Slices were tested for viability
with PI (5 M) before the oxygen–glucose deprivation (OGD) experi-
ments. Healthy slices fromWT and bax/mice were transferred to the
hypoxic chamber (COY Lab Products). The hypoxic chamber had an
atmosphere comprising 1.5%O2, 5%CO2, and 85%N2, and the temper-
ature was maintained at 35°C. The slices were transferred to wells con-
taining pre-equilibrated and deoxygenatedOGDmedium (bubbled with
N2 for 1 h before use). The OGDmedium consisted of the following (in
mM): 2 CaCl2, 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2MgSO4,
and 10 sucrose, pH 6.8. After 45 min of OGD, the slices were transferred
to fresh oxygenated culture medium and placed in normoxic conditions
(21% O2 and 5% CO2), and PI uptake was observed over a 24 h period.
Control slices were free fromOGD. Images were acquiredwith an Eclipse
TE 300 invertedmicroscope (Nikon) and a 4 dry objective withWasabi
Software version 5.0 (Hamamatsu Photonics). The CA1 region was se-
lected from WT and bax/ hippocampal slices after OGD treatment,
and the mean fluorescent intensity was determined. The regional gray-
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level intensity was measured using the Wasabi interactive tool, back-
ground gray-level was corrected, and the average intensitywas plotted for
nine slices per treatment. Neuronal injury was expressed as percentage of
total injury (OGD performed for 4 h and recovery for 24 h).
After each time point, slices were placed into a six-well plate without
media and 90 l of lysis buffer [2% SDS (w/v), 67.5 mM Tris/Cl, pH 6.8,
and 10% glycerol] was added to each insert containing three slices. Slices
were removed by using a pipette and then transferred into an Eppendorf
1 ml tube. The protein was then stored at80°C.
SDS-PAGE andWestern blotting. Preparation of cell lysates andWest-
ern blotting was performed as described previously (Reimertz et al.,
2003). The resulting blots were probed with the following: a mouse
monoclonal -fodrin (II-Spectrin) antibody (clone AA6; Millipore)
diluted 1:1000; a rabbit polyclonal calpain large subunit antibody (Cell
Signaling Technology) diluted 1:500; a rabbit polyclonal green fluores-
cent protein (GFP) antibody (peptide 26–39; Calbiochem) diluted
1:1000; and a mouse monoclonal -actin antibody (clone DM 1A;
Sigma) diluted 1:5000. Horseradish peroxidase-conjugated secondary
antibodies diluted 1:10,000 (Pierce) were detected using SuperSignal
West Pico Chemiluminescent Substrate (Pierce) and imaged using a Fu-
jiFilm LAS-3000 imaging system (FujiFilm).
Plasmids, transfections, and shRNA. Neocortical neurons (DIV 6) and
NSC34 cells were transfected using Lipofectamine 2000 (Invitrogen),
whereas SH-SY5Y cells were transfected with TurboFect In Vitro Trans-
fection Reagent (Fermentas). The membrane-targeted calpain-sensitive
Fo¨rster resonance energy transfer (FRET) probe pSCLPaX, containing
the calpain-specific spectrin substrate linker, was prepared as follows.
Complementary oligonucleotides 5GCAG CAGGAGGTGTACGGAG-
GTAC3 and 5CTCCGTACACCTCCTGCTGCAGCT3 were annealed
and ligated into SacI and KpnI sites between enhanced cyan fluorescent
protein (ECFP) and Venus in the FRET probe subcloning vector pTK-
reverse SCAT (Hellwig et al., 2008). This generated a cassette consisting of a
coding sequence for the calpain substrate sequenceQQEVYG flanked at the
N terminus by ECFP, a serine tripeptide, and an SacI site (encoding glu-
tamate–leucine) and at the C terminus by a KpnI site (encoding glycine–
threonine), a flexible serine–glycine–serine tripeptide, and Venus. The
oligonucleotide sequences immediately adjacent to the overhangs were
designed to destroy the SacI site during ligation with corresponding vec-
tor overhangs and generate a diagnostic PvuII site to facilitate exclusion
of constructs withmultiple concatenated oligonucleotides. The resulting
pTK-reverse SCLPa vector was digested with BsrGI to generate a BsrGI
site-flanked DNA fragment including calpain substrate motif and Venus
coding sequence. This was inserted in-frame into the BsrGI site of the
membrane-targeted ECFP expression vector pECFP–CAAX to generate
the plasmid pSCLPaX. pECFP–CAAX was generated by replacing the
coding sequence for EGFP in the plasmid pEGFP–CAAX (Hongisto et
al., 2008) with the coding sequence for ECFP, using the enzymes AgeI
and BsrGI. For overexpression of calpastatin, cells were transfected with
a vector expressing GFP–calpastatin (MG209946; OriGene). For inhibi-
tion of calpain, cells were transfected with a vector expressing either a
commercial shRNA targeting the large subunit of calpain I (SHCLNG-
NM_007600, TRCN0000030664; Sigma) or the large subunit of calpain II
(SHCLNG-NM_009794, TRCN0000030672; Sigma) or a scramble control
vector (SHC001; Sigma). A plasmid with an enhanced GFP (pEGFP–N1;
Clontech) was used to allow the identification of transfected neurons. Cells
were used for experiments 36 h after transfection.
Real-time live-cell imaging. Primary neocortical neurons on Willco
dishes were coloaded with Fluo-4 AM (3M) and TMRM (20 nM) for 30
min at 37°C (in the dark) in experimental buffer containing the following
(in mM): 120 NaCl, 3.5 KCl, 0.4 KH2PO4, 20 HEPES, 5 NaHCO3, 1.2
Na2SO4, 1.2 CaCl2, and 15 glucose, pH 7.4. The cells were washed and
bathed in 2ml of experimental buffer containingTMRM, and a thin layer
ofmineral oil was added to prevent evaporation.Neuronswere placed on
the stage of an LSM 510Meta confocal microscope equipped with a 63,
1.3 NA oil-immersion objective and a thermostatically regulated cham-
ber (Carl Zeiss). After 30 min equilibration time, neurons were exposed
to NMDA-induced excitotoxic injury (30 M NMDA for 5 min, 100 M
NMDA for 5 min, or 300 M NMDA for 60 min), and glycine (10 M)
with MK-801 (5 M) was added to block NMDA receptor activation as
required. TMRM was excited at 543 nm, and the emission was collected
with a 560 nm long-pass filter; Fluo-4 AMwas excited at 488 nm, and the
emission was collected through a 505–550 nm barrier filter. Images were
captured every 30 s during NMDA excitation and every 5min during the
rest of the experiments. In separate experiments, neurons, transfected
with the calpain-sensitive FRET probe and loaded with TMRM (20 nM)
in experimental buffer, were placed on the stage of an LSM5Live duoscan
confocal microscope equipped with a 40, 1.3 NA oil-immersion objec-
tive and a thermostatically regulated chamber set at 37°C (1080; Carl
Zeiss). After a 30 min equilibration time, drug dissolved in experimental
buffer was added to the medium. TMRMwas excited at 561 nm, and the
emission was collected by a 575 nm long-pass filter. CFP was excited at
405 nm, and emission was collected at 445–505 and 505–555 nm for
FRET. Yellow fluorescent protein (YFP) was excited directly using the
489 nm laser diode and detected with the same bandpass filter used for
FRET. Images were captured every 5 min throughout these experiments.
All microscope settings, including laser intensity and scan time, were
kept constant for the whole set of experiments. Control experiments
under these conditions were also performed and showed that photo tox-
icity had a negligible impact. The cell-permeable Ca2 chelator
BAPTA-AM (500 nM) was used for TMRM/Fluo-4 AM and calpain-
FRET probe experiments andwas added to themediumon stage 4 h after
the NMDA exposure. The donor unquenching control experiment was
performed in neurons transfected with the FRET probe on the LSM 5live
duoscan using the same mode of detection as stated above, except the
missing delay between consecutive scans. Bleach scans were performed
using the point scanner of the microscope to scan predefined regions
only with the 489 nm diode-pumped solid-state laser acousto-optic tun-
able filter transmission set to 100% and using an 80/20 beam splitter to
bleachVenus (see Fig. 6C). All images were processed and analyzed using
MetaMorph Software version 7.5 (Universal Imaging), and the data were
presented normalized to the baseline response.
Statistics. Data are given as means	 SEM. For statistical comparison,
one-way ANOVA followed by Tukey’s post hoc test was used. p values

0.05 were considered to be statistically significant.
Results
Treatment with the calpain inhibitor calpeptin reduces
delayed excitotoxic apoptosis in cortical neurons
To explore the role of calpains in excitotoxic neuronal injury, we
used three models of NMDA-induced excitotoxicity in primary
mouse cortical neurons. Cortical neurons were exposed to either
NMDA (30 or 100M) for 5 min (Fig. 1A) or 300MNMDA for
60 min (Fig. 1B). Controls were sham exposed to experimental
buffer. Confocal imaging of individual Ca2 responses using
Fluo-4 AM demonstrated that neurons (1) completely and per-
sistently recovered their cytosolic Ca2 to stable basal levels after
termination of theNMDAexposure (Fig. 1C), (2) recovered their
cytosolic Ca2 levels after the NMDA exposure but showed a
delayed Ca2 deregulation (DCD) (Fig. 1D), or (3) failed to
recover their NMDA-induced increase in intracellular Ca2 and
showed an immediate and sustained Ca2 deregulation (ICD)
(Fig. 1E). We classified neurons according to these Ca2 re-
sponses into three groups designated “tolerant,” “apoptotic/
DCD,” and “necrotic/ICD” (Ankarcrona et al., 1995;Ward et al.,
2007). Parallel imaging of mitochondrial membrane potential
(m) changes demonstrated thatDCDwas associatedwith a late
mitochondrial depolarization (Fig. 1D), whereas neurons under-
going ICD showed an early and persistent depolarization (Fig.
1E). In neurons exposed to 100 M for 5 min, DCD occurred
always subsequent to the delayed mitochondrial membrane po-
tential depolarization within a period of 30	 2 min. Some neu-
rons characterized by an ICD response still showed nuclear
pyknosis (data not shown), suggesting that cells with an ICD
response did not show a homogenously “necrotic” nuclear mor-
phology. Neurons displaying an ICD response after a 60 min
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exposure to 300 M NMDA were insensi-
tive to bax-gene deletion (Fig. 1G). Neu-
rons undergoing DCD showed chromatin
condensation primarily in the absence of
nuclear fragmentation (Fig. 2A) and may
therefore be classified as “type II” apopto-
tic neurons (Leist and Ja¨a¨ttela¨, 2001).
Quantification of the individual Ca2
responses in relation to the different inten-
sities of NMDA receptor overactivation
demonstrated that the mild NMDA expo-
sure of 30 M for 5 min [peak Fluo-4 fluo-
rescence, 1.94	 0.13 arbitrary units (AU)]
primarily produced neuronal tolerance,
whereas the 5 min exposure to 100 M
NMDA (peak Fluo-4 fluorescence, 2.47	
0.14 AU) produced a mix of DCD and
ICD responses, with DCD responses be-
ing more prominent. In contrast, pro-
longed exposure of 300 M NMDA for 60
min induced primarily ICD (Fig. 1F).
QuantificationofPI-positive cells, amarkerof
plasmamembrane leakage occurring after
primary or secondary necrosis, likewise
indicated that prolonged exposure of 300
M NMDA for 60 min caused significant
amounts of immediate cell death within
1 h, whereas cell death induced by a 5min
exposure to 30 or 100 MNMDA showed
amore delayed profile with amaximal on-
set at 4 h (Fig. 1H).
Because the highest fraction of DCD
and ICDwere detectedwith 100M/5min
and 300 M/60 min NMDA, respectively,
additional experiments were conducted
in these two injurymodels. To explore the
role of calpains in mediating excitotoxic
injury, neurons were pretreated with the
selective calpain inhibitor calpeptin (5–20
M) for 2 h and then exposed to NMDA.
When neurons were exposed to condi-
tions that favored DCD, calpeptin treat-
ment exerted a robust dose-dependent
and long-term neuroprotective effect as
detected by phase-contrast microscopy,
Hoechst 33258 staining, and quantifica-
tion of PI uptake (Fig. 2A–C). Treatment
with calpeptin also reduced the accumu-
lation of the calpain-specific, 145 kDa
spectrin breakdown product that accu-
mulated in NMDA-exposed cultures as
determined by quantitative Western
blot analysis. Significant increases in
spectrin cleavage were observed at 4 –8
h compared with the sham-treated cul-
tures and reduced in cultures pretreated
with calpeptin (Fig. 2D). Surprisingly,
however, pretreatment with calpeptin failed to show a signif-
icant protection under conditions that favor ICD, as induced
by the exposure to 300 M NMDA for 60 min (Fig. 2E). This
was confirmed by the analysis of the accumulation of the 145
kDa, calpain-specific spectrin breakdown product that accu-
mulated only marginally in the neuron cultures (Fig. 2F).
Gene silencing of calpain I and II or overexpression of
calpastatin confirms the selective requirement for calpain
activation in delayed excitotoxic apoptosis
Because pharmacological agents may have off-target effects, we
next investigated whether the selective requirement of calpains in
delayed excitotoxic apoptosis could be confirmed using genetic
Figure 1. NMDA receptor overactivation produces distinct types of neuronal responses as evidenced by single-cell imaging:
tolerance, apoptosis, and necrosis. A,B, Models of excitotoxic NMDA receptor overactivation. The neuronswere exposed to 30M
NMDA for 5min, 100MNMDA for 5min, or 300MNMDA for 60min, afterwhich alterations inmand intracellular Ca
2were
monitored in single cells using time-lapse confocal fluorescencemicroscopy (LSM 510Meta). C–E, Three neuronal responseswere
readily identifiable (Ward et al., 2007): C, DCD/tolerant neuronwith recovery of neuronal Ca 2 overloading and extensive hyper-
polarization ofm; D, excitotoxic apoptosis in which neuronal mitochondria transiently recovered their energetics and a late
m depolarization and DCD occurred hours after the initial excitation; E, ICD/necrosis with an acute and ICD associated with a
rapid collapse of membrane potential. F, Quantification of cellular responses for the three injury models (n 102, n 109, n
129 for 30 M/5 min, 100 M/5 min, and 300 M/60 min treatments, respectively). Data were obtained from at least three
independent experiments.G, Quantification of cellular responses in neurons frombax/mice (n61neurons) andWT controls
(n 129 neurons) treated with 300M NMDA for 60 min. H, NMDA induces dose-dependent excitotoxicity over time. Cortical
neuronswere treatedwith 30MNMDA for 5min, 100MNMDA for 5min, 300MNMDA for 60min, or shamconditions for 5min
and allowed to recover as indicated. Cell death was assessed by Hoechst and PI staining. Three subfields containing 300–400
neurons eachwere captured, and at least threewellswere analyzed per time point. PI-positive nuclei were scored as dead neurons
and expressed as a percentage of the total population. Data are means	 SEM from n 3 separate cultures. Ctrl, Control. *p
0.05 compared with NMDA-treated control. #p 0.05 between NMDA treatments (ANOVA, post hoc Tukey’s test).
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approaches. Gene silencing of the large subunit of calpain I
and II using two distinct shRNA constructs was validated in
NSC34 cells after 36 h of transfection when compared with
cultures transfected with a scramble vector as determined by
Western blot analysis (Fig. 3A). Of note, transfection with
either shRNA targeting the large calpain subunit significantly
reduced cell death in response to 100 M/5 min NMDA com-
pared with cells transfected with a scrambled shRNA sequence
(Fig. 3B). In contrast, immediate cell death in response to 300
M/60 min NMDA was not reduced by gene silencing of the
large calpain subunit (Fig. 3C).
Inhibition of calpain activity can also be achieved by overex-
pression of the endogenous calpain inhibitor calpastatin. Neu-
rons were transfected with a mammalian expression vector for
Figure2. Calpain inhibitor calpeptinprotects neurons against excitotoxic apoptosis.A, Representative images of phase-bright and themerged imageof PI- andHoechst-stainedneurons exposed
to sham conditions or 100M NMDA for 5 min in the presence and absence of the calpain inhibitor calpeptin. Images were taken at selected time points (8 and 24 h after treatment). Scale bar, 10
m. B, Dose–response assay. Neurons were treated with 100M NMDA for 5 min in the presence (5 or 20M) or absence of calpeptin for the indicated times. The number of PI-positive cells was
expressedas apercentageof total cells in the field. Data representmeans	SEMfromn3 separate cultures. *p0.05 comparedwithNMDA-treated controls. #p0.05betweenNMDA-treated
neurons in the presence of calpeptin (5 or 20M) (ANOVA, post hoc Tukey’s test). C, E, Cortical neuronswere treatedwith 100M NMDA for 5min over 24 h (C) or 300M NMDA for 60min over 4 h
(E) in the presence or absence of calpeptin, and the extent of injury was assessed with Hoechst and PI. Data represent means	 SEM from n 3 separate cultures. *p 0.05 compared with
NMDA-treated controls (ANOVA, post hoc Tukey’s test).D, F,Western blot and densitometric analysis comparing the levels of spectrin cleavage in neurons after NMDA treatments: 100MNMDA for
5min over 24 h (D) or 300M NMDA for 60min over 4 h (F ) in the presence or the absence of calpeptin.-Actin was used as loading control. Experiments were repeated three timeswith different
preparations with similar results. Densitometric data are expressed as a ratio of the 145 kDa spectrin breakdown product (BP) and the 280 kDa full-length (FL) protein normalized to-actin. *p
0.05 compared with NMDA-treated controls. #p 0.05 between NMDA-treated neurons in the presence or absence of calpeptin (ANOVA, post hoc Tukey’s test).
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calpastatin–GFP or with an EGFP control
vector. Analysis of GFP-positive neurons
indicated that transfection of calpastatin–
GFP significantly reduced excitotoxic cell
death in response to 100 M/5 min
NMDA (Fig. 3D). Again, immediate cell
death in response to 300 M/60 min
NMDA was not reduced by calpastatin–
GFP (Fig. 3E). These results confirmed
that calpains played a predominant role in
excitotoxic apoptosis.
The protective activity of calpain
inhibition requires a functional
mitochondrial apoptosis pathway
We next explored whether calpain acted on
Bcl-2 family proteins to promote excito-
toxic apoptosis.Onepossibilitywas that cal-
pains activated pro-apoptotic Bcl-2 family
proteins of the Bcl-2 homology 3 domain-
only family. Bid represents a prominent
candidate for such an activity. Bid is in-
volved in the so-called extrinsic apoptosis
pathway and is proteolytically activated by
caspase-8 to generate a truncated form
(tBid) (Li et al., 1998; Luo et al., 1998). It has
also been suggested that calpain-mediated
cleavageofBidgeneratesBid fragments that,
similar to tBid, may activate the mitochon-
drial apoptosis pathway (Chen et al., 2001;
Polster et al., 2005). However, cortical neu-
rons from bid-deficient mice were equally
sensitive to the NMDA-induced delayed
excitotoxic cell death asWT neurons (Fig.
4A,B). Furthermore, calpeptin also ex-
erted significant neuroprotection in bid-
deficient neurons, demonstrating that
calpains were not acting on Bid to pro-
mote cell death (Fig. 4B).
In contrast, bax-deficient cortical neurons
werehighly resistant toNMDA-inducedexci-
totoxic apoptosis (Fig. 4C). Moreover, cal-
peptin failed to provide a significant
protection in bax-deficient mice, suggest-
ing that deficiency in bax was dominant over the pro-apoptotic
activity of calpain and that calpains required a functional mito-
chondrial apoptosis pathway to mediate excitotoxic apoptosis.
Quantification of the individual Ca2 responses in response
to a 100 M/5 min NMDA exposure showed increased neuronal
tolerance in the bax-deficient mice compared with the WT con-
trols, as evidenced by decreased DCD responses (Fig. 4D). Of
note, bax gene deletion also led to a significant reduction in ICD
responses after the exposure to 100M/5minNMDA, suggesting
that ICD may accompany several cell-death modes or that bax
gene deletion has an effect on neuronal Ca2 handling.
Calpains are activated during bax-dependent neuronal injury
induced by OGD
To validate our hypothesis that activation of calpains played a
predominant role in bax-dependent cell death in a clinicallymore
relevant setting, we performed experiments using OHSCs sub-
jected to OGD. OGD is a widely used in vitromodel of ischemic
injury that also produces apoptotic (Kalda et al., 1998) and ne-
crotic (Goldberg and Choi, 1993; Gwag et al., 1995) cell-death
phenotypes. OHSCs derived from WT and bax-deficient mice
were exposed to OGD for 45 min in the absence or presence of
calpeptin (20 M) and allowed to recover under normoxic con-
ditions over 24 h. As shown in Figure 5B, a 45 min OGD treat-
ment was sufficient to induce CA1 damage in WT OHSCs,
whereas the neuronal injury in bax-deficient slice cultures was
significantly attenuated. Calpeptin treatment exerted a signifi-
cant neuroprotective effect in WT OGD-treated OHSCs but not
in the bax-deficient slice cultures (Fig. 5A,B). Western blot anal-
ysis revealed an increased accumulation of the calpain-specific,
145 kDa spectrin breakdown product in the WT OHSCs but not
in the bax-deficient slice cultures (Fig. 5C).
Calpain activation occurs late during excitotoxic apoptosis
Our experiments demonstrated a functional role of calpains dur-
ing delayed excitotoxic apoptosis but did not provide detailed
information when during the cell-death signaling cascade cal-
pains became activated. To provide spatiotemporal information
Figure 3. Calpain inhibition using RNA interference technology and overexpression of the endogenous calpain inhibitor calpastatin
attenuateNMDA-induced excitotoxic apoptosis.A, NSC34 cellswere transfectedwith shRNAplasmids against the large subunit of calpain
I (shRNA I), calpain II (shRNA II), or scramble shRNA. Reduced expression levels of calpain I and II after shRNA expression compared with
scramble were assessed by Western blotting 36 h after transfection. Probing for-actin served as a loading control. Experiments were
repeated three timeswith similar results.B, C, Cell-death analysis after 100MNMDA treatment for 5min assayed over 24h (B) and 300
MNMDAfor60min treatmentassayedover4h (C). Cortical neurons were transfected with shRNA plasmids as described above.
A plasmid expressing GFP allowed for the identification of transfected neurons. The number of PI-positive cells in trans-
fected neurons was quantified (n 125–160 cells per time point quantified). Experiments were performed in triplicate in
three separate cultures. *p 0.05 comparedwithNMDA-treated, scramble transfected controls (ANOVA, post hoc Tukey’s test).
D, E, Cortical neuronswere transfectedwith a plasmid expressing the endogenous calpain inhibitor, calpastatin fusedwith GFP, or
a plasmid expressing GFP alone as a control. Neuronswere treatedwith 100MNMDA for 5min and assayed over 24 h (D) and 300
MNMDA for 60minandassayedover 4h (E). Thenumberof PI-positive cells in transfectedneuronswasquantified (n142–173
cells per time point quantified). *p 0.05 compared with NMDA-treated controls (ANOVA, post hoc Tukey’s). Experiments were
repeated three times with independent culture preparations with similar results.
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on calpain activation and its relation to cell death during excito-
toxic injury, we designed a calpain-sensitive FRET probe com-
prisingCFP andVenus as FRETdonor and acceptor, respectively,
and an 18 aa linker that incorporated the QQEVYG calpain-
cleavage site of spectrin. The intact FRET probe was anchored to
the plasmamembrane by a CAAX targeting sequence (for details,
see Materials and Methods). During calpain activation, FRET
probe cleavage of the linker peptide results in FRET disruption
that can be detected by confocal time-lapsemicroscopy (Fig. 6A).
To confirm that the FRET probe was reporting calpain cleavage,
we transfected humanneuroblastoma SH-SY5Y cells with the FRET
probe.After this, cellswere exposed to ionomycinandCaCl2, a treat-
ment that results in significant and rapid calpain activation in SH-
SY5Y cells (Reimertz et al., 2001). Western blot analysis of cytosolic
extracts demonstrated that endogenous full-length spectrin was
Figure 4. Protection by calpeptin depends on a functional mitochondrial apoptosis pathway. A,
RepresentativestandardPCRanalysisofgenomicDNAshowsindicatedstrainandexpectedPCRbands
sizesforbidandbaxgenotyping.M,100bpladder;NC,negativecontrolwithoutthetailDNAtemplate.
B, C, Neocortical neurons from bid/mice, bax/mice, andWT controls were treatedwith 100
MNMDAfor5minover24horshamconditionsfor5mininthepresenceorabsenceofcalpeptin.Cell
deathwasassessedbyHoechstandPIstaining,andtheresultswerequantifiedasapercentageoftotal
neurons in the field. Each field contained300–400 neurons, three fields were captured per well,
andat leastthreewellswereanalyzedpertimepoint.Means	SEMareshown.*p0.05compared
with NMDA-treated WT controls. #p  0.05 compared with NMDA-treated knock-out controls
(ANOVA, post hoc Tukey’s test).D, Quantification of cellular responses in neurons from bax/mice
(n 373 neurons) andWT controls (n 275 neurons) treatedwith 100MNMDA for 5min. Data
were obtained from at least four independent experiments. Means	 SEM are shown. *p 0.05
comparedwithNMDA-treatedWT controls (ANOVA,post hoc Tukey’s test).
Figure 5. OHSCs isolated from bax-deficient mice show reduced calpain activation in re-
sponse to OGD. A, Representative images of OHSCs derived from WT and bax/ mice. The
slices were sham exposed or subjected to OGD conditions for 45min in the absence (control) or
presence of calpeptin (20M) andallowed to recover for 24h. Scale bar, 100m.B, Hippocam-
pal slice cultures fromWT and bax/mice were treated as described in A, and quantification
of injury was assessed by PI staining 24 h after treatment (n 5 slice cultures for each condi-
tion). Means	 SEM are shown. *p 0.05 compared with OGD-treated WT control (ANOVA,
post hoc Tukey’s test). C,Whole-cell extractswere prepared fromWTand bax/ hippocampal
slice cultures treated to 45 min OGD and allowed to recover under normoxic conditions for the
indicated time points. Spectrin cleavage was assessed by Western blotting.-Actin served as
loading control. BP, Breakdown product; FL, full-length.
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cleaved with similar kinetics than the intact
FRET probe (detected using a GFP anti-
body) during addition of ionomycin and
CaCl2. Moreover, we detected a similar in-
crease in the accumulation of the 145 kDa,
calpain-spectrin cleavage product and the
cleaved FRETprobe (Fig. 6B, left). Cleavage
of the FRET probe was also sensitive to a
treatment with calpeptin (Fig. 6B, right).
To explore the calpain-sensitive FRET
probe efficiency, we next performed ac-
ceptor photobleaching experiments in
control neurons. After establishment of a
baseline, repeated bleaching stepswere re-
corded and allowed a clear detection of
donor unquenching (using similar image
acquisition settings as in the following
time-lapse experiments). The unquench-
ing was complete after five consecutive
bleaching steps as indicated in Figure 6C.
Having established that the FRET
probe was functional and reported cal-
pain activity, we transfected the probe
into cortical neurons and exposed them to
100MNMDA for 5min (conditions that
favor the induction of delayed excitotoxic
apoptosis) or 300 M NMDA for 60 min
(conditions that favor ICD; see Fig. 1). Be-
cause ICD and DCD were associated with
mitochondrialmembrane potential depo-
larization (Fig. 1), we detected in parallel
changes in mitochondrial membrane po-
tential using the membrane-permeant
cationic fluorescent probe TMRM. Inter-
estingly, in neurons that showed a delayed
excitotoxic apoptosis, we detected signifi-
cant FRET probe cleavage. However, this
occurred always subsequent to the de-
layed mitochondrial depolarization (Fig.
7A), within a period of 42 	 8 min (Fig.
7C). This suggested that calpains were
predominantly activated during the exe-
cution phase of delayed excitotoxic apo-
ptosis. Calpain activity lasted on average
58	 13min. Onset of cell death, detected
by the sudden loss of cytosolic CFP fluo-
rescence attributable to plasma mem-
brane leakage, occurred always after onset
of the FRET probe cleavage and with an
average delay of 96 	 8 min (Fig. 7C). In
contrast, cells exposed to 300 M NMDA
for 60 min did not show significant FRET
probe cleavage either before or during ICD
(Fig. 7B). Analysis of all cellsmonitored and
classified according to their type of response
(tolerant, DCD, or ICD) revealed that cal-
pain FRET probe cleavage was selectively
detected incells that showedDCD(Fig. 7D).
In contrast, neither tolerant cells nor cells
undergoing ICD showed a detectable FRET
probe cleavage.
To investigate whether the DCD was a
trigger for calpain activation in this system,
Figure 6. FRET-based single-cell analysis of calpain activity. A, The calpain-sensitive FRET probe consisted of CFP and Venus
fluorophores linked together by a region containing the calpain-substrate spectrin sequence. The Venus fluorophore is fused to a
CAAX motif. During cleavage of the spectrin linker, the FRET between CFP and Venus is disrupted. This results in decreased FRET
fluorescent intensity and increased CFP fluorescent intensity. B, FRET probe expression and cleavage in vitro was validated by
Westernblotting in SH-SY5Y cells usingananti-GFPantibody. After FRET-probe transfection, the cellswere treatedwith ionomycin
(5M) and CaCl2 (10 mM) for the indicated times in the presence () or absence () of calpeptin.-Actin was used as loading
control. BP, Breakdown product; CL, cleavage; FL, full-length. C, The Venus bleaching and correlating CFP unquenching kinetics
were performed on the LSM 5live duoscan in control neurons transfected with the FRET probe. From the fifth scan onward, each
scan of a time serieswas followedby ableach scan, as indicated by red triangles. On the bottom, corresponding time-frame images
of the cell are illustrated. Bleached region, used to calculate the average intensity kinetics, is indicated in red and segmented for the
cell area using the CFP channel. Scale bar, 10m.
1854 • J. Neurosci., February 1, 2012 • 32(5):1847–1858 D’Orsi et al. • Calpains Mediate Excitotoxic Apoptosis
we treated murine cortical cultures on
stage with the Ca2 chelator BAPTA-AM
(500 nM). BAPTA-AM is a membrane-
permeable chelator that has been shown to
be neuroprotective against excitotoxicity
and is more selective and faster compared
with other Ca2 chelators, such as EGTA
and EDTA (Tymianski et al., 1994). Excito-
toxic injurywas induced in cortical neurons
by an exposure to 100MNMDAfor 5min,
and BAPTA-AM (500 nM) was added 4 h
after termination of the NMDA exposure.
Analysis of the onset ofm depolarization
and DCD using TMRM and Fluo-4-based
confocal fluorescence microscopy showed
that BAPTA-AMdid not produce a consid-
erabledelay in theonsetof them loss (Fig.
7E) but resulted in a significant delay in
DCD (Fig. 7F). Furthermore, BAPTA-AM
produced a robust delay in the onset of FRET
probe cleavage compared with NMDA-
exposed control neurons (Fig. 7G).
Discussion
In thepresent study,wehave set out to char-
acterize the role of calpains in response to
transient and prolonged glutamate receptor
overactivation in mouse neocortical neu-
Figure7. Calpain activation is selectively associatedwith excitotoxic apoptosis.A,B, Cortical neuronswere transfectedwith the
calpain-sensitive FRET probe and after 24 hmounted on the stage of a LSM 5Live duoscan, and neuronswere treatedwith 100M
NMDA for 5min and assayed over 24h (A) or 300MNMDAand assayed over 4 h (B). Fluorescentmeasurementswere recorded for
TMRM, FRET, CFP, andYFPby time-lapse confocalmicroscope. FRETprobe imagingdata are expressedas a ratio of CFP/FRET. TMRM
was used as am indicator in the nonquenchedmode. In neurons that showed a delayed excitotoxic apoptosis (A), we observed
4
significant calpain activation (FRET probe cleavage) subse-
quent to delayed m depolarization. In neurons that
showed an immediate excitotoxic ICD/necrosis (B), no signifi-
cant FRET cleavagewasobserved. Theonset of these events (in
red and green) and cell death (in black) is indicated by arrows
(A, B), and representative time-frame images are illustrated
(left, pseudocolored CFP/FRET emission ratio; red, TMRM im-
ages). Scale bar, 10 m. C, Analysis of FRET probe cleavage
and its relation to cellular outcome in cells treated with 100
M NMDA for 5 min. Data shown represent the mean time
takenbetween theonset of FRETprobedisruption andonset of
m loss; the mean time taken for complete probe cleavage
and the mean time taken between onset of FRET probe cleav-
age and onset of cellular collapse. Datawere obtained from18
separate experiments from 11 independent cultures (n 22
neurons). D, Quantification of the number of cells in 100M
NMDA/5 min treated neurons with FRET probe disruption (in
black, total number of cells; in gray, cells with FRET probe dis-
ruption). Neurons were classified according to their type of
cellular response (DCD, tolerance, ICD). Data were obtained
from 18 separate experiments from 11 independent cultures
(n 47 neurons). E, F, Cortical neurons were exposed to 100
M NMDA for 5 min and the Ca 2 chelator BAPTA-AM (500
nM)wasaddedon stage4hafterNMDAaddition.Alterations in
m and intracellular Ca
2 were monitored in single cells
using confocal fluorescencemicroscopy. Onset ofm loss (E)
and onset of DCD (F) was analyzed in neurons in the absence
(control, n 29 neurons) or the presence of BAPTA-AM (n
19 neurons). *p 0.05 compared with NMDA-treated con-
trol.G, Cortical neurons transfected with the calpain-sensitive
FRET probe were treated as described in E and F and the onset
of the FRET probe cleavage was analyzed in transfected neu-
rons in the absence (control, n 11 neurons) or presence of
BAPTA-AM (n  11 neurons). *p  0.05 compared with
NMDA-treated control neurons.
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rons. Our data suggest that, surprisingly, calpains do not contribute
to excitotoxic injury under conditions that are associated with ICD
and excitotoxic necrosis. Using pharmacological, genetic, and
single-cell imaging approaches, we demonstrate that calpains rather
play a critical role in bax-dependent, excitotoxic apoptosis and are
here activated as cell-death effectors during the execution stage.
Our study supports the concept that inhibitionof calpain activity
provides neuroprotection against excitotoxic neuronal injury. One
of the limitations in our studymay be that calpain inhibition slowed
downcell death rather than arresting it.However, similar neuropro-
tective effects were observed in hippocampal and cortical neurons
subjected to excitotoxic andOGD-induced neuronal injury in vitro,
using the calpain inhibitors calpeptin, MDL-28170, and E-64 (Si-
man et al., 1989; Brorson et al., 1995;Rami et al., 1997; Lankiewicz et
al., 2000). Similarly, neuroprotection was also observed using ge-
netic approaches. Knockdown of-calpain (calpain I) in an in vitro
model of OGD was able to prevent AIF nuclear translocation and
increased cell survival (Cao et al., 2007). Moreover, calpain inhibi-
tionwasneuroprotective in in vivomodels of excitotoxic injury (Wu
et al., 2004), ischemic stroke, and neurodegeneration (Lee et al.,
1991; Rami and Krieglstein, 1993; Bartus et al., 1994; Hong et al.,
1994). It has also been reported that knockdown of calpain II (m-
calpain) increased survival of primary hippocampal neurons after
NMDA excitotoxicity (Bevers et al., 2009). Importantly, previous
studies did not fully address the question under which cell-death
conditions calpain inhibition is neuroprotective andwhen in the cell
death cascade calpains became activated. In this study, we demon-
strate that calpains are specifically involved in bax-dependent exci-
totoxic apoptosis. Although treatment with calpeptin failed to show
any significant protection in neurons undergoing ICD, it provided a
long-termprotection in neurons undergoingDCD/excitotoxic apo-
ptosis. These findings were confirmed using genetic approaches, in-
cluding gene silencing of calpain and overexpression of the
endogenous inhibitor calpastatin (Fig. 3). Western blot data also
suggested that, under conditions that favor ICD, calpain-specific
spectrin proteolysis was not significantly elevated, whereas neurons
exposed to conditions that favor DCD showed significant calpain
activation(Fig.2).Thesebiochemicaldatawereconfirmedbysingle-
cell imaging experiments, in which no significant cleavage of the
calpain-sensitive FRET probe was detected in the soma of neurons
that underwent ICD, whereas neurons undergoing DCD showed a
full-blown calpain activity (Fig. 7).
These data bring up the question why ICD did not trigger a
prominent calpain activation on neuronal somata despite the
very significant increase in cytosolic Ca2. A prolonged gluta-
mate excitation is characterized by a rapid collapse of cellular
bioenergetics and rapid ATP depletion (Tymianski et al., 1993;
Ankarcrona et al., 1995; Budd and Nicholls, 1996; Vergun et al.,
1999; Luetjens et al., 2000; Ward et al., 2007). It is possible that
the activation of calpains requires an energy-dependent process
and a substantial amount of ATP to be present. Alternatively,
ICD-associated membrane rupture and cell death may occur too
rapidly to allow for a controlled calpain activation. We cannot
exclude that calpains were still activated locally and in defined
structures, such as dendrites, or were activated at undetectable
levels. However, our data demonstrate that any such activity did
not contribute to cell death in neurons that underwent ICD.
Our experiments also demonstrate that delayed excitotoxic
apoptosis required a functional, bax-dependent mitochondrial
apoptosis pathway and that calpains work within this pathway as
cell-death executioners. Our data did not show a bid requirement
for excitotoxic apoptosis or for calpain-dependent cell death, be-
cause bid-deficient and WT mice were similarly sensitive to
NMDA-induced apoptosis, and calpain inhibition was equally
protective in bid-deficient and WT mice (Fig. 4). Polster et al.
(2005) suggested in isolated mitochondria studies that calpain-
dependent Bid cleavage triggers the release of pro-apoptotic fac-
tors from mitochondria. In intact neurons, such a mechanism
may not operate in the setting of excitotoxic apoptosis.
Notably, our study demonstrates that calpain activation oc-
curred downstream ofmitochondrial engagement during excito-
toxic apoptosis. These findings and the observation that
excitotoxic apoptosis is bax-dependent elicit two related and im-
portant questions: (1) why does excitotoxic injury not trigger a
prominent caspase activation, and (2) why do calpains represent
the cell-death executioners during bax-dependent excitotoxic ap-
optosis whereas in other models of bax-dependent neuronal ap-
optosis, such as staurosporine exposure, caspases, but not
calpains, function as executioners (Lankiewicz et al., 2000)? A key
factor may be the extent of mitochondrial Ca2 overloading in
such paradigms. After the initial NMDA-induced cytosolic Ca2
increase, neurons not only pumpCa2 back into the extracellular
compartment but also reestablish their cytosolic Ca2 levels by
mitochondrial Ca2 uptake (Nicholls and Scott, 1980; Ward et
al., 2005). A bax-dependentmitochondrial outermembrane per-
meabilization (MOMP) will, however, cause mitochondrial de-
polarization as a result of the loss of cytochrome c (Goldstein et
al., 2000; Luetjens et al., 2000). This may trigger a Ca2 release
from the mitochondrial matrix, capable of activating calpains.
Indeed, previous studies have shown that DCD is absent when
MOMP is blocked (Concannon et al., 2010). Our calpain–FRET
imaging data support such a hypothesis: activation of calpains
occurred downstream of m depolarization and with a delay
similar to that of DCD (Figs. 1–7). Furthermore, delayed appli-
cation of the Ca2 chelator BAPTA-AM after NMDA exposure
led to significant delay in DCD and calpain activation. However,
this does not rule out a possible contribution of other factors,
such as growth factor- and MAPK-dependent calpain activation
(Zadran et al., 2010). Because other neuronal apoptosis para-
digms do not induce a similar mitochondrial Ca2 overloading,
activation of calpains may be less pronounced or absent (Lankie-
wicz et al., 2000). Once activated, calpains inhibit the ability of
cytochrome c to activate caspases by cleavage of procaspase-3 and
procaspase-9, as well as APAF-1 (Chua et al., 2000; Lankiewicz et
al., 2000; Reimertz et al., 2001). As a consequence, a caspase-
independent excitotoxic apoptosis ensues that is mediated by
calpains. Calpains cleave a variety of proteins that are required for
neuronal function, including cytoskeletal proteins and transcrip-
tion factors (Croall and Demartino, 1991). Calpains also process
and trigger AIF release from mitochondria and may thereby in-
duce cell death (Cregan et al., 2002; Wang et al., 2004; Cao et al.,
2007). Calpains may also further increase neuronal Ca2 over-
loading by cleavage and inactivation of the Na/Ca 2 ex-
changer (Bano et al., 2005). Indeed, the overexpression of
calpastatin or of a noncleavable Na/Ca 2 exchanger has
been shown to inhibit DCD during excitotoxic neuronal in-
jury (Bano et al., 2005). Activation of calpains may therefore
initiate a self-amplifying Ca2-dependent cell death cascade,
eventually resulting in the destruction of the neuron.
In conclusion, our study demonstrates that calpains play a
critical role in bax-dependent excitotoxic apoptosis but contrib-
ute little to the destruction of neuron during excitotoxic necrosis.
This mechanism may be of particular importance for the treat-
ment of neuronal injury associated with submaximal glutamate
receptor overactivation as evident in the ischemic penumbra or
during chronic neurodegeneration.
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